Drug Shortages Near an All-Time High, Leading to Rationing

The New York Times (05/17/2023)
  • Drug shortages in the US are nearing record highs, impacting treatment availability for patients suffering from life-threatening diseases, particularly cancer.
  • Ryan Dwars (pictured) couldn’t receive his final four doses of chemotherapy.
  • Factors contributing to this shortage include disrupted supply chains, quality concerns, and manufacturing shutdowns.
  • The scarcity of generic drugs (90% of US prescriptions) has created delays in treatment and is prompting Congress to act.
  • There is debate over potential remedies including tax incentives for generic drug makers and increased transparency around drug quality.